Advanced nanotechnology for hypoxia-associated antitumor therapy

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Hypoxia, or low oxygen, is a critical characteristic of the tumor microenvironment.
• Tumor hypoxia promotes cancer proliferation, metastasis, invasion, and resistance to therapy, leading to recurrence.
• Nanotechnology offers promising strategies to overcome tumor hypoxia and enhance cancer treatment efficacy.

Purpose of the Study:

• To review and analyze nanotechnology-based strategies for overcoming tumor hypoxia.
• To explore methods for modulating the hypoxic tumor microenvironment for improved therapeutic outcomes.
• To guide the clinical application of advanced nanotechnology in hypoxia-associated antitumor therapy.

Main Methods:

• Review of existing nanotechnology strategies targeting tumor hypoxia.
• Categorization of strategies based on their mechanism of action (e.g., oxygen delivery, consumption reduction).
• Analysis of approaches including bioreductive prodrug activation, targeted delivery, oxygen generation, and vessel normalization.

Main Results:

• Nanotechnology can effectively alleviate tumor hypoxia through various mechanisms.
• Strategies include reducing oxygen consumption, normalizing tumor vasculature, delivering exogenous oxygen, and generating oxygen in situ.
• In situ oxygen production represents a refined and expanding strategy.

Conclusions:

• Nanotechnology-based hypoxia modulation is crucial for enhancing cancer treatment efficacy.
• Overcoming tumor hypoxia is essential for preventing treatment resistance and recurrence.
• Advanced nanotechnology holds significant potential for clinical translation in hypoxia-driven cancer therapy.